Evaluating Pancreatic Enzyme Replacement Therapy (PERT) supplements in pancreatic cancer treatment
Completed
- Conditions
- Pancreatic cancerMalabsorption
- Registration Number
- ACTRN12617000801314
- Lead Sponsor
- urse Maude Association
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method